Jan 2022

myOnsite Healthcare (MOH) is thrilled to announce the launch of myWork – Phlebotomist App:

myOnsite Healthcare (MOH) is excited to announce the launch of myWork- the myOnsite mobile application that connects mobile phlebotomists with clients in need of healthcare services across the nation. MOH is dedicated to the development and integration of mobile healthcare services that benefit all types of patients leading to optimized healthcare access.

myWork was designed for the mobile phlebotomist by one of the leading mobile phlebotomy companies with the idea to streamline services thereby enabling convenience, scheduling and reach capacity. myWork allows mobile phlebotomists to provide much needed services on their own schedule with more flexibility, freedom, and money. With myWork, phlebotomists can choose when and where* they want to work based on available client service requests.

The myWork app conveniently has all you need to sign up, schedule clients and get paid in one location. myWork is equipped with a document management system, appointment calendar, location services, notification features, service checklists, laboratory requisition and label printouts, and end-to-end logistics from sample pick up and delivery. Only a few requirements are needed to get started. To learn more about the myWork app and how you can join our mobile team visit our career page online located at https://myonsitehealthcare.com/ or contact us directly at [email protected].

May 2021

myOnsite completed the NYC Sero surveillance project Phase 2 with a success rate of 85% .

The New York City Department of Health and Mental Hygiene (DOHMH) has partnered with myOnsite for Covid Sero-Surveillance collections since the Covid pandemic population-based serology survey informs decisions about prevention and control strategies as well as community mitigation interventions. Our team of qualified professionals scheduled and conducted at-home phlebotomy services across the five boroughs of New York city. myOnsite is responsible for collecting blood specimens, transporting all specimens in an appropriate and timely manner, and properly disposing of biohazardous waste generated in the process. 

During Phase 1 myOnsite contacted 96% of the total participants within 3 days and 90% of the draws were completed successfully. Due to the participants’ diversity, we designed a new workflow in our mobile application for E-consent with a digital signature facility in four different languages (Russian, Cantonese, Spanish, and English). To meet the language barriers and solve the queries, we assigned a dedicated multi-Lingual  24*7 phone lines and a customer service team for the entire NYC project.

The client was delighted with our dedication and hard work and awarded us with the further project. We completed phase 2 with 45% more draw volume than phase 1 and a higher success rate of 85%. We are currently working on phase 3 of the project.

NIH partnered with myOnsite for a multi-site national Covid project.

We are proud to announce our partnership with NIH (National Institutes of Health) and Leidos Biomedical Research Inc, a technical contractor for Frederick National Laboratory for Cancer Research. This is a phase 3 multi-site project of covid positive patients affected by cancer or other health conditions. myOnsite will be handling end-to-end mobile specimen collection for the site requiring home visits and access to our LIS portal for scheduling and managing the specimen collection with real-time updates. 

myOnsite sealed the New Hampshire state Biomonitoring program project.

MOH is now the exclusive partner of DHHS-NH (NH Department of Health & Human Services) for the New Hampshire state Biomonitoring programs. MOH will work with DHHS-NH on four projects spanning a cumulative period of 4 years. The project is to study the environmental safety and health risk of individuals in the industrial towns of New Hampshire. myOnsite will be managing the entire specimen collection process paperless with real-time updates.

myOnsite ventured into the Biohacker community market segment for specimen collection services.

We are glad to announce that we have extended our specimen collection services to perform complicated draws for the Biohacker community in collaboration with OpenCures, Inc., for various study subjects. Biohackers are self-volunteers who get themselves tested and enrolled in healthcare programs and contribute to the scientific community. myOnsite will be collaborating with them to manage all the nationwide specimen collections.

24*7 dedicated assistant to our clients.

During such unprecedented times, we recognize the special responsibility we have as healthcare providers. We actively work around the clock to serve healthcare providers and government agencies at both the federal and city levels to support their Covid-19 efforts and provide comprehensive, value-based quality care and patient-centric solutions for our patients and healthcare providers. We have upgraded the support team to provide 24 x 7 better and timely support to our clients on HL7 projects and assist them with further queries.

myOnsite now offers tailored options for your EMR system and print customized labels.

We continuously strive to provide effective tech-savvy solutions to ease and fasten the process for our clients. We offer a paperless workflow that spans from initial ordering to final results with real-time updates. And to further streamline the specimen management process, we now provide tailor-made solutions to integrate client’s EMR systems and print customized labels according to the client’s protocols and requirements. This will help our clients to manage their workflow and duties more effectively, eliminate human mistakes and increased accuracy. These thermal labels give more convenience,  flexibility and versatility in the healthcare field and create a safe work environment. It has benefitted many of our clients like Memorial Sloan Kettering Cancer Center (MSK) in New York. 

The laboratory information system is upgraded to provide a better and detailed experience.

We believe in value-based patient care and client-centricity. To provide the best quality, we offer the most advanced and effective solution and constantly strive to upgrade our systems and software to provide cutting-edge technology and user-friendly options to make the specimen management process convenient and easy for healthcare providers. We have recently upgraded our Laboratory information system (LIS), providing detailed and better data in graphical formats with customized options. Different users from the same organization can now have individual dashboards that can be customized to view data that matters to them. Now we can get quick and early notifications of adverse incidents into our incident management system, which helps us take immediate actions and provide solutions for a better and smooth workflow between the client and myOnsite.

December 2020

myOnsite demonstrates a commitment to International Quality standards.

myOnsite is pleased to announce that we are working toward becoming ISO 9001 certified by mid-2021. As the fastest growing mobile phlebotomy company in the United States, myOnsite is prepared to meet the challenges that rapid expansion brings. We are dedicated to providing consistent quality of service, and certification of our policies and procedures will be a benchmark achievement. ISO certification will bring confidence to new partners and existing customers that we will continue to provide the outstanding customer service and quality partnerships that we are known industry-wide for providing.

The New York City Department of Health partners with myOnsite for their Sero Surveillance program.

The New York City Department of Health and Mental Hygiene (DOHMH) has partnered with myOnsite for Covid Sero-Surveillance collections since the Covid pandemic conducting a population-based serology survey inform decisions about prevention and control strategies as well as community mitigation interventions. Our team of qualified professionals is visiting the homes of study participants across the five boroughs of New York City to collect blood specimens, transport all specimens in an appropriate and timely manner, and properly dispose of waste biohazardous waste generated in the process. We were able to initiate the project within a week of notification and have already completed phase 1 and soon begin with Phase 2.

myOnsite helping New York city schools reopen safely.

In support of Governor Cuomo’s executive order of mandatory COVID testing of students and teachers in the yellow zone schools, myOnsite now offers fully managed Covid-19 Testing for New York Schools at a deep discount. We will assign a dedicated Project Manager for each school and digitally manage the entire process by allowing schools to complete access to our web portal to review all the results. myOnsite will provide a list of positive tests for NY State as per reporting regulations.

myOnsite has been awarded two US defense medical research studies and one rare disease study.

We are happy to announce the launch of two prestigious Defense projects, for which we are providing mobile specimen collection services. One of the projects is a biomedical study and the other study is a patient population study related to Obesity. The Projects are quite complex and we are managing the entire process from specimen collection, processing to reporting the results. We are also enabling instrument interfaces through our web portal system.

We are also working on a project for conducting research services for rare diseases. This project’s biggest challenge is that the collection has to be conducted for participants in remote counties. We are solving the last mile leg of the clinical research industry challenge, that the participants from remote counties are unable to reach the sites and travel far. We have also enabled the transportation of the samples post collection and consenting process with seamless tracking.

myOnsite can now service you in 22 states with 250% more phlebotomists in the field.

myOnsite provides a one-stop solution for all Mobile Phlebotomy. Especially during this pandemic, patients should not be afraid to seek care for any new or existing health conditions. We recognize the special responsibility we have as healthcare providers. We are actively working around the clock to serve government agencies at both the federal and city levels to support their Covid-19 efforts. We also serve some of the most vulnerable populations who rely on the healthcare service we provide. We have increased our team by 250% to meet our client’s needs and are continually adding to our available services, such as now Clinical Research and COVID Testing.

We will soon be expanding our reach in 50 states.

To ensure we offer the best of the services and improve the business, we have expanded our coverage and currently servicing 22 states across the nation. With regards to customer satisfaction we have consistently worked on it and improved on it by ensuring consistent Increase in Ontime draws which stands at about 85%. We are in the process of increasing our coverage by doubling the coverage further across the nation by Dec-2020 so that we can have better / more reach and service more customers.